Concepedia

Nayon Kang

NK

Statistics

Publications

6

Citations

180

H-Index

6

Active since

2012

Affiliations

Medical Research Council(Current)

University of Minnesota

Stanford University

University College London

Baylor College of Medicine

Nayon Kang is an author at Medical Research Council specializing in pharmacy, infectious diseases, and pharmacotherapy.

Publications per year

2012–2024

6

Publications

6

The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19

Deborah Wentworth, Andrew Phillips, Kathryn Shaw‐Saliba et al. · Annals of Internal Medicine · 2022 · 63 citations · Full text

, , +15

Drug Release Patterns and Cytotoxicity of PEG-poly(aspartate) Block Copolymer Micelles in Cancer Cells

Allison M. Eckman, Eleftheria Tsakalozou, Nayon Kang et al. · Pharmaceutical Research · 2012 · 41 citations

, , +16

Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19

Eleftherios Mylonakis, Barnaby Edward Young, David M. Vock et al. · Annals of Internal Medicine · 2022 · 31 citations · Full text

, , +13

Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial

Samuel M. Brown, Christina E. Barkauskas, Birgit Grund et al. · The Lancet Respiratory Medicine · 2023 · 19 citations · Full text

, , +13

Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19

Neil R. Aggarwal, Jacquie Nordwall, Dominique L. Braun et al. · Clinical Infectious Diseases · 2024 · 16 citations · Full text

, , +15

1–5 of 6